|Bid||0.00 x 3100|
|Ask||0.00 x 3000|
|Day's Range||23.58 - 24.40|
|52 Week Range||19.34 - 46.32|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||48.40|
|Earnings Date||Nov. 03, 2021 - Nov. 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||62.50|
Xoma (XOMA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EMERYVILLE, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA)’s Chief Executive Officer, Jim Neal, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 28, 2021, at 10:20 AM PT. About XOMA CorporationXOMA is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeuti
A look at the shareholders of XOMA Corporation ( NASDAQ:XOMA ) can tell us which group is most powerful. Generally...